Neoadjuvant immunotherapy of oral squamous cell carcinoma modulates intratumoral CD4/CD8 ratio and tumor microenvironment: a multicenter phase II clinical trial.
Tímár J, Ladányi A, Forster-Horváth C, Lukits J, Döme B, Remenár E, Godény M, Kásler M, Bencsik B, Répássy G, Szabó G, Velich N, Suba Z, Elo J, Balatoni Z, Pócza K, Zemplén B, Chretien P, Talor E.
Tímár J, et al. Among authors: remenar e.
J Clin Oncol. 2005 May 20;23(15):3421-32. doi: 10.1200/JCO.2005.06.005.
J Clin Oncol. 2005.
PMID: 15908653
Clinical Trial.